guideSEQ: Genomic Understanding, Impact, Decision & Ethics in Prenatal Sequencing

Part of paid clinical trials in Boston, Massachusetts.

Sponsor
Columbia University
Study ID
NCT07610590
Status
Recruiting

Conditions

  • Prenatal Genetic Diagnosis

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Genome Sequencing (GS) — GENETIC
    Genome sequencing (GS) is a genetic test that involves reading the genome to identify genetic changes (also known as "genetic variants") that can cause differences in human development and disease.

Study Details

This study looks at whether genome sequencing should be used more routinely during pregnancy, even when ultrasounds look normal. Genome sequencing can examine nearly all of a baby's genes and may find genetic conditions that standard tests do not detect. Researchers will compare this test with current prenatal testing to see if it provides helpful information for families and doctors. The study will also explore how parents decide what kinds of genetic information they want to receive and how this information affects their experience during pregnancy. The goal is to understand whether genome sequencing can be used in a way that is helpful, responsible, and supportive for families in the future.

Key Dates

Start date
Apr 29, 2026
Status verified
May 2026
Primary completion
Jul 31, 2029
Completion
Jul 31, 2029

Study Design

Enrollment
1,042 participants (estimated)

Primary Outcome Measure

Incremental Genomic Frequency [ Time Frame: Baseline to 12 months postpartum. ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
Boston Childrens HospitalBostonMassachusetts02115-
Columbia University Irving Medical Center (CUIMC)New YorkNew York10032
Camila Zarate, MPH
646-300-0197
Jessica Giordano, MS, CGC
516-521-5604
Ronald Wapner, MD (PRINCIPAL_INVESTIGATOR)
New York Genome CenterNew YorkNew York10013-

Find similar trials in Boston, MA